Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury-Reference-Cited by-同舟云学术

Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury

Published:2007-02 Issue:1 Volume:3 Page:1-8
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Huang Yi-Shin

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.3.1.1

Reference55 articles.

1. FARRELL GC: Drug-induced acute hepatitis. In:Drug-inducedLiverDisease.Farrell GC (Ed.), Churchill Livingstone, Edinburgh, UK (1994):262-272.

2. GARG PK, TANDON RK: Antituberculosis agents-induced liver injury. In:Drug-inducedLiverDisease.Kaplowitz N, Deleve LD (Eds), Marcel Dekker, New York, USA (2003):505-517.

3. Anti-Tuberculosis Drug Induced Hepatotoxicity and Genetic Polymorphisms in Drug-metabolizing Genes

4. Polymorphism of theN-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Pharmacogenetics Markers of Human NAT2 Gene in Tuberculosis Treatment;Pharmaceutical Science;2024-05-29

2. Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity;Experimental & Molecular Medicine;2024-03-01

3. Nutritional intervention is promising in alleviating liver injury during tuberculosis treatment: a review;Frontiers in Nutrition;2023-09-21

4. N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study;Frontiers in Pharmacology;2023-08-31

5. Role of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis;Current Pharmacology Reports;2022-01-17